Home
Conditions
Recurrent Colon Cancer

Clinical trial condition

Recurrent Colon Cancer

Explore clinical trials studying Recurrent Colon Cancer. Study availability and eligibility vary by location and protocol.

55 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Colon Cancer trial results

Completed

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

NCT01105377

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

University of Southern California/Norris Cancer Center Los Angeles, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View all 14 locations

View Trial Details

Completed

Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment

NCT00942266

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors

NCT01217450

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +17 more
Locations: National Cancer Institute Medicine Branch Bethesda, Maryland, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

Wisconsin Clinical Cancer Center Milwaukee, Wisconsin, United States

View Trial Details

Completed

RO4929097 in Treating Patients With Metastatic Colorectal Cancer

NCT01116687

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

NCT00504153

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer

NCT00134069

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +16 more
Locations: University of Colorado at Denver Health Sciences Center Aurora, Colorado, United States

Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

NCT00060411

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +26 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

NCT00138177

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +17 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Recurrent Colon Cancer

Recurrent Colon Cancer trial results

Related conditions